|
Biotecnologia Aplicada
Elfos Scientiae
ISSN: 0684-4551
Vol. 12, Num. 2, 1995, pp. 86-87
|
Revista Biotecnologia Aplicada 12(2): 86-87 (1995)
REPORTE CORTO/SHORT REPORT
Presented in the Congress Biotecnologia Habana 94. La Habana,
Cuba, Nov. 28 - Dec. 3, 1994
PRESENCE OF HEPATITIS C VIRAL RNA IN SERUM OF PATIENTS WITH
NON-A, NON-B HEPATITIS IN CUBA DETECTION BY PCR
Juan Morales-Grillo, Mario Barro, Ariel Vina, Cesar R. Gomez,
Ciro Garcia, Odalys Garcia.
Vaccine Department. Center for Genetic Engineering and
Biotechnology. P.O. Box. 6162. C.P.10600. Havana. Cuba(53-
7)218070.
Code Number: BA95027
File Sizes:
Text: 6K
No associated graphics
INTRODUCTION
Hepatitis C is the major causative agent of post transfusion and
sporadic non-A, non-B Hepatitis in the world (1). Although the
commercial kits containing several epitopes of the Hepatitis C
virus are available for the screening of HCV infection, they only
reflect the immune response and do not indicate active viremia.
There is a need for a reliable marker that differentiates ongoing
HCV infection with viremia from resolved or past infections. To
discriminate between these possibilities, a direct test for the
presence of HCV would be invaluable. Due to the relatively small
quantities of viral RNA found in serum and liver tissues of
infected individuals it can not be detected by the conventional
hybridization techniques (2).
Recently, HCV RNA detection by PCR reaction has been used to
diagnose Hepatitis C in patients with non-A, non-B Hepatitis (3).
The aim of this study was to detect the presence of HCV RNA in
serum of patients with chronic non-A, non-B Hepatitis in Cuba.
MATERIALS AND METHODS
The 18 samples used in this study were previously tested using
UBI HCV EIA and LIA TEK HCV, commercial kits (supplied by Organon
Teknika B.V., Oss, The Netherlands). All patients were
seropositive for both anti-HCV assays (4). The primers were
derived from the highly conserved 5'-noncoding region (5), based
on alignment of previously published HCV sequence (6). RNA was
prepared by the proteinase K-SDS method described previously (3).
For cDNA synthesis, the RNA and random primers were denatured
together at 95 C for 3 min and incubated at 42 C for 1 h with
avian Myeloblastosis virus reverse transcriptase (Boehringer) as
described by Sambrook et al. (7).
The PCR reaction was performed in 100 uL mixture containing 5 uL
of specific cDNA and 50 picomole of each outer primer. The PCR
reaction was carry out in 35 cycles of 94 C for 1 min, 60 C for
1 min and 72 C for 1 min., followed by a 5 min final extension
at 72 C. For the nested amplification, 10 ul from the first
reaction were added to a similar PCR reaction mixture as the
former, but with the inner primers. PCR was carried out for 35
cycles as described for the first amplifications but the
annealing temperature was 65 C.
Ten microlitres of nested PCR final reaction was analyzed by
electrophoresis through 1.5% agarose gel and by Southern blot
using the internal probe labelled with 32P (7). To avoid
contamination the precautions recommended by Kwok et
al.(8) were used.
RESULTS AND DISCUSSION
All the 18 patients were positive for HCV RNA. The observed size
of the RT-PCR products was around 230 bp in the ethidium bromide-
stained agarose gel and was consistent with the expected length
of 229 bp between the two primers used for nested PCR. The
specificity of these products was confirmed by hybridization to
radiolabelled internal oligonucleotide used as probe in the
Southern blot. No additional bands were seen in the agarose gel
or in the autoradiogram. The HCL RNA was detected in all patients
positive to antibodies anti-HCV and previously diagnosed with a
chronic hepatitis. It was not detected in the healthy individual
used as negative control who was also seronegative for anti-HCV
antibodies.
In our study, the HCV RNA was detected in all Cuban patients,
with chronic Hepatitis C, seropositive for anti-HCV assays and
revealed that viremia was highly associated with anti-HCV
antibodies. The same good correlation was reported by others (9,
10).
The detection of HCV RNA using the 5'UT region primers in the 18
samples confirm the importance of using primers from this region,
which is the most well conserved of the genome among all strains
of HCV isolated up to date (6). We conclude that our RT-PCR is
a highly sensitive assay for detection of HCV sequences in serum.
It could be useful as a confirmatory test for the diagnosis of
acute Hepatitis C infection and for identifying viremia in the
chronic disease.
REFERENCES
1. ALTER, H. J. R. et al. (1989). N. Engl. J.
Med. 321: 1494-1500.
2. CHOO, Q. L. et al. (1989). Science 244:
359-362.
3. GARSON, J. A. et al. (1990). Lancet
336: 1419-1422.
4. PADR N, G. et al. (1993) FEMS Symposium, Istanbul,
Turkey.
5. OKAMOTO, H. et al. (1990). Jpn. J. Med.
60: 167-177.
6. GARC A, O. (1994). M. Sci. Thesis, Havana University,
Cuba.
7. SAMBROOK, J. M. et al., (1989). Molecular Cloning:
A Laboratory Manual. 2nd ed. CSH, N. Y.
8. KWOK, S. and R. HIGUCHI (1989). Nature (London)
339: 237-238.
9. WANG, J. T. et al. (1992). Vox Sang.
62: 21-24.
10.HAGIWARA, H. et al. (1992). Gastroenterology
102: 692-694.
Copyright 1995 Sociedad Iberolatinoamericana de Biotecnologia
Aplicada a la Salud
|